188 related articles for article (PubMed ID: 31490705)
21. Expression of RUNX2 and Osterix in Rat Mesenchymal Stem Cells during Culturing in Osteogenic-Conditioned Medium.
Pokrovskaya LA; Nadezhdin SV; Zubareva EV; Burda YE; Gnezdyukova ES
Bull Exp Biol Med; 2020 Aug; 169(4):571-575. PubMed ID: 32910396
[TBL] [Abstract][Full Text] [Related]
22. Myocilin stimulates osteogenic differentiation of mesenchymal stem cells through mitogen-activated protein kinase signaling.
Kwon HS; Johnson TV; Tomarev SI
J Biol Chem; 2013 Jun; 288(23):16882-16894. PubMed ID: 23629661
[TBL] [Abstract][Full Text] [Related]
23. Oxysterols regulate differentiation of mesenchymal stem cells: pro-bone and anti-fat.
Kha HT; Basseri B; Shouhed D; Richardson J; Tetradis S; Hahn TJ; Parhami F
J Bone Miner Res; 2004 May; 19(5):830-40. PubMed ID: 15068507
[TBL] [Abstract][Full Text] [Related]
24. Symphytum officinale augments osteogenesis in human bone marrow-derived mesenchymal stem cells in vitro as they differentiate into osteoblasts.
Dey D; Jingar P; Agrawal S; Shrivastava V; Bhattacharya A; Manhas J; Garg B; Ansari MT; Mridha AR; Sreenivas V; Khurana A; Sen S
J Ethnopharmacol; 2020 Feb; 248():112329. PubMed ID: 31672526
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-346-5p Regulates Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells by Inhibiting Transmembrane Protein 9.
Zhang Y; Sun Y; Liu J; Han Y; Yan J
Biomed Res Int; 2020; 2020():8822232. PubMed ID: 33299881
[TBL] [Abstract][Full Text] [Related]
26. FAK Promotes Osteoblast Progenitor Cell Proliferation and Differentiation by Enhancing Wnt Signaling.
Sun C; Yuan H; Wang L; Wei X; Williams L; Krebsbach PH; Guan JL; Liu F
J Bone Miner Res; 2016 Dec; 31(12):2227-2238. PubMed ID: 27391080
[TBL] [Abstract][Full Text] [Related]
27. Zoledronic Acid-Loaded β-TCP Inhibits Tumor Proliferation and Osteoclast Activation: Development of a Functional Bone Substitute for an Efficient Osteosarcoma Treatment.
Kameda Y; Aizawa M; Sato T; Honda M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672879
[TBL] [Abstract][Full Text] [Related]
28. Consistent osteoblastic differentiation of human mesenchymal stem cells with bone morphogenetic protein 4 and low serum.
Cordonnier T; Langonné A; Sohier J; Layrolle P; Rosset P; Sensébé L; Deschaseaux F
Tissue Eng Part C Methods; 2011 Mar; 17(3):249-59. PubMed ID: 20822481
[TBL] [Abstract][Full Text] [Related]
29. Imbalanced Osteogenesis and Adipogenesis in Mice Deficient in the Chemokine Cxcl12/Sdf1 in the Bone Mesenchymal Stem/Progenitor Cells.
Tzeng YS; Chung NC; Chen YR; Huang HY; Chuang WP; Lai DM
J Bone Miner Res; 2018 Apr; 33(4):679-690. PubMed ID: 29120093
[TBL] [Abstract][Full Text] [Related]
30. 3,5-dicaffeoyl‑epi-quinic acid from Atriplex gmelinii enhances the osteoblast differentiation of bone marrow-derived human mesenchymal stromal cells via WnT/BMP signaling and suppresses adipocyte differentiation via AMPK activation.
Karadeniz F; Oh JH; Lee JI; Seo Y; Kong CS
Phytomedicine; 2020 Jun; 71():153225. PubMed ID: 32464299
[TBL] [Abstract][Full Text] [Related]
31. Energy Metabolism During Osteogenic Differentiation: The Role of Akt.
Smith CO; Eliseev RA
Stem Cells Dev; 2021 Feb; 30(3):149-162. PubMed ID: 33307974
[TBL] [Abstract][Full Text] [Related]
32. Bisphosphonates hinder osteoblastic/osteoclastic differentiation in the maxillary sinus mucosa-derived stem cells.
Zhang J; Park J; Lee JW; Kwon YD; Kim EC
Clin Oral Investig; 2018 Jun; 22(5):1933-1943. PubMed ID: 29188452
[TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor inhibits mesenchymal stem cell differentiation into osteoblasts via the ubiquitin E3 ligase Wwp1.
Zhao L; Huang J; Zhang H; Wang Y; Matesic LE; Takahata M; Awad H; Chen D; Xing L
Stem Cells; 2011 Oct; 29(10):1601-10. PubMed ID: 21809421
[TBL] [Abstract][Full Text] [Related]
34. A2B adenosine receptor promotes mesenchymal stem cell differentiation to osteoblasts and bone formation in vivo.
Carroll SH; Wigner NA; Kulkarni N; Johnston-Cox H; Gerstenfeld LC; Ravid K
J Biol Chem; 2012 May; 287(19):15718-27. PubMed ID: 22403399
[TBL] [Abstract][Full Text] [Related]
35. TM9SF4 is a novel regulator in lineage commitment of bone marrow mesenchymal stem cells to either osteoblasts or adipocytes.
Yu L; Xie M; Zhang F; Wan C; Yao X
Stem Cell Res Ther; 2021 Nov; 12(1):573. PubMed ID: 34774100
[TBL] [Abstract][Full Text] [Related]
36. O-GlcNAc modification of the runt-related transcription factor 2 (Runx2) links osteogenesis and nutrient metabolism in bone marrow mesenchymal stem cells.
Nagel AK; Ball LE
Mol Cell Proteomics; 2014 Dec; 13(12):3381-95. PubMed ID: 25187572
[TBL] [Abstract][Full Text] [Related]
37. Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms.
Otsuru S; Gordon PL; Shimono K; Jethva R; Marino R; Phillips CL; Hofmann TJ; Veronesi E; Dominici M; Iwamoto M; Horwitz EM
Blood; 2012 Aug; 120(9):1933-41. PubMed ID: 22829629
[TBL] [Abstract][Full Text] [Related]
38. Zoledronic acid inhibits osteoclastogenesis and bone resorptive function by suppressing RANKL‑mediated NF‑κB and JNK and their downstream signalling pathways.
Huang XL; Liu C; Shi XM; Cheng YT; Zhou Q; Li JP; Liao J
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34935053
[TBL] [Abstract][Full Text] [Related]
39. MiR-125b Regulates the Osteogenic Differentiation of Human Mesenchymal Stem Cells by Targeting BMPR1b.
Wang H; Xie Z; Hou T; Li Z; Huang K; Gong J; Zhou W; Tang K; Xu J; Dong S
Cell Physiol Biochem; 2017; 41(2):530-542. PubMed ID: 28214897
[TBL] [Abstract][Full Text] [Related]
40. Pax2 is essential for proliferation and osteogenic differentiation of mouse mesenchymal stem cells via Runx2.
Lu M; Guo S; Hong F; Zhang Y; Yuan L; Ma C; Ma J
Exp Cell Res; 2018 Oct; 371(2):342-352. PubMed ID: 30144446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
